Dalle Carbonare, L., Bertoldo, F. and Lo Cascio, V. (1) “Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project”, Reumatismo, 61(1), pp. 54-64. doi: 10.4081/reumatismo.2009.54.